J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kennedy, M. J.
Right arrow Articles by Leeder, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kennedy, M. J.
Right arrow Articles by Leeder, J. S.

DRUG METABOLISM

Comparison of Various Urine Collection Intervals for Caffeine and Dextromethorphan Phenotyping in Children

Mary Jayne Kennedy, PharmD, Susan M. Abdel-Rahman, PharmD, Angela D. M. Kashuba, PharmD and J. Steven Leeder, PharmD, PhD

From the Division of Pediatric Clinical Pharmacology and Medical Toxicology, The Children's Mercy Hospitals and Clinics, Kansas City, Missouri (Dr. Kennedy, Dr. Abdel-Rahman, Dr. Leeder); the Departments of Pediatrics (Dr. Kennedy, Dr. Abdel-Rahman, Dr. Leeder), Pharmacy Practice (Dr. Kennedy), and Pharmacology (Dr. Abdel-Rahman, Dr. Leeder), the University of Missouri-Kansas City, Kansas City, Missouri; and the Division of Pharmacotherapy, School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (Dr. Kashuba).

Caffeine and dextromethorphan have been used successfully both alone and in combination to assess phenotype and enzyme activity in children of various ages. Previous pediatric phenotyping studies with these agents have used varying durations of urine collection. However, the minimum duration required for accurate phenotypic assessment with these compounds in children remains unknown. We calculated the cumulative metabolite recoveries and molar ratios in urine collected from children for 2, 4, 6, and 8 hours after caffeine and dextromethorphan administration to determine when respective urinary molar ratios stabilize and thus likely accurately reflect enzyme activity. Subjects (n = 24, ages 3-8 years) were given 4 oz of Coca-Cola® (~11.5 mg caffeine) and a single oral dose of dextromethorphan (0.5 mg/kg). Urine was collected at discrete intervals (0-2, 2-4, 4-6, and 6-8 h) during an 8-hour period, and the cumulative metabolite recoveries and urinary molar ratios were calculated. CYP2D6 genotyping was also performed in 21 of 24 subjects. In CYP2D6 extensive metabolizers, the extent of recovery for relevant metabolites was equivalent by 4 hours and represented 45% to 60% of the total amount recovered in the 8-hour period. The 2-hour CYP1A2 ratio was significantly different from those of longer collection intervals. Metabolite ratios for all other enzymes (i.e., NAT-2, XO, and CYP2D6) were independent of the duration of urine collection. These data suggest that a 4-hour urine collection is adequate for the concurrent assessment of hepatic CYP1A2, NAT-2, XO, and CYP2D6 activity in children ages 3 to 8 years who are CYP2D6 extensive metabolizers, using standard caffeine and dextromethorphan phenotyping methods. Longer collection periods may be required, however, in younger children or CYP2D6 poor metabolizers.


Key Words: Caffeinedextromethorphanphenotypingurine collectionpediatrics

Address for reprints: Mary Jayne Kennedy, PharmD, Assistant Professor of Pediatrics and Pharmacology/Toxicology, Associate Director, Kosair Charities Pediatric Clinical Research Unit, Department of Pediatrics, University of Louisville, 231 E. Chestnut Street, N97, Louisville, KY 40202.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
K. Allegaert, B. J. Anderson, R. Verbesselt, A. Debeer, J. de Hoon, H. Devlieger, J. N. Van Den Anker, and D. Tibboel
Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity
Br. J. Anaesth., August 1, 2005; 95(2): 231 - 239.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Clinical Pharmacology